MENU
+Compare
AMLX
Stock ticker: NASDAQ
AS OF
Jun 27 closing price
Price
$6.50
Change
-$0.00 (-0.00%)
Capitalization
564.26M

AMLX Amylyx Pharmaceuticals Forecast, Technical & Fundamental Analysis

Amylyx Pharmaceuticals Inc is a clinical-stage pharmaceutical company working on developing a novel therapeutic for amyotrophic lateral sclerosis and other neurodegenerative diseases... Show more

AMLX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for AMLX with price predictions
Jun 27, 2025

AMLX's Stochastic Oscillator is remaining in overbought zone for 1 day

Expect a price pull-back in the near future.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The RSI Indicator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where AMLX declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

AMLX broke above its upper Bollinger Band on June 24, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on June 24, 2025. You may want to consider a long position or call options on AMLX as a result. In of 56 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for AMLX just turned positive on June 24, 2025. Looking at past instances where AMLX's MACD turned positive, the stock continued to rise in of 29 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where AMLX advanced for three days, in of 207 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 129 cases where AMLX Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. AMLX’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.801) is normal, around the industry mean (16.366). P/E Ratio (2.814) is within average values for comparable stocks, (58.189). AMLX's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.309). Dividend Yield (0.000) settles around the average of (0.041) among similar stocks. P/S Ratio (3.627) is also within normal values, averaging (252.247).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. AMLX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
AMLX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

AMLX is expected to report earnings to rise 7.52% to -45 cents per share on August 07

Amylyx Pharmaceuticals AMLX Stock Earnings Reports
Q2'25
Est.
$-0.45
Q1'25
Beat
by $0.20
Q4'24
Beat
by $0.01
Q3'24
Missed
by $0.37
Q2'24
Missed
by $0.34
The last earnings report on May 08 showed earnings per share of -41 cents, beating the estimate of -62 cents. With 1.44K shares outstanding, the current market capitalization sits at 564.26M.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
43 Thorndike Street
Phone
+1 617 682-0917
Employees
384
Web
https://www.amylyx.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
TBWCX19.970.21
+1.06%
Thornburg Better World International C
AFCSX18.930.19
+1.01%
American Century Focused Intl Gr I
FGIQX16.020.06
+0.38%
Macquarie Growth and Income R6
MSHPX15.22N/A
N/A
Morgan Stanley Inst Permanence R6
VGENX48.24-0.05
-0.10%
Vanguard Energy Inv

AMLX and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, AMLX has been loosely correlated with GRI. These tickers have moved in lockstep 57% of the time. This A.I.-generated data suggests there is some statistical probability that if AMLX jumps, then GRI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AMLX
1D Price
Change %
AMLX100%
N/A
GRI - AMLX
57%
Loosely correlated
-0.78%
SLRX - AMLX
54%
Loosely correlated
-0.01%
RGNX - AMLX
45%
Loosely correlated
-4.11%
DNLI - AMLX
45%
Loosely correlated
-2.69%
OCUL - AMLX
44%
Loosely correlated
-2.54%
More

Groups containing AMLX

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AMLX
1D Price
Change %
AMLX100%
N/A
AMLX
(2 stocks)
46%
Loosely correlated
N/A